vorinostat has been researched along with Adenoma in 4 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
Adenoma: A benign epithelial tumor with a glandular organization.
| Excerpt | Relevance | Reference |
|---|---|---|
| "MMR-deficient colorectal cancers are classically characterized by right-sided location, multifocality, mucinous histology, and lymphocytic infiltration." | 1.35 | Epigenetic repression of DNA mismatch repair by inflammation and hypoxia in inflammatory bowel disease-associated colorectal cancer. ( Afrasiabi, K; Birnbaumer, L; Edwards, RA; Lipkin, SM; Pham, T; Wang, K; Witherspoon, M, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lu, J | 1 |
| Chatain, GP | 1 |
| Bugarini, A | 1 |
| Wang, X | 1 |
| Maric, D | 1 |
| Walbridge, S | 1 |
| Zhuang, Z | 1 |
| Chittiboina, P | 1 |
| Fatemi, M | 1 |
| Paul, TA | 1 |
| Brodeur, GM | 1 |
| Shokrani, B | 1 |
| Brim, H | 1 |
| Ashktorab, H | 1 |
| Sangeetha, SR | 1 |
| Singh, N | 1 |
| Vender, JR | 1 |
| Dhandapani, KM | 1 |
| Edwards, RA | 1 |
| Witherspoon, M | 1 |
| Wang, K | 1 |
| Afrasiabi, K | 1 |
| Pham, T | 1 |
| Birnbaumer, L | 1 |
| Lipkin, SM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation and Treatment of Neurosurgical Disorders[NCT00060541] | 5,000 participants (Anticipated) | Observational | 2003-06-04 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 other studies available for vorinostat and Adenoma
| Article | Year |
|---|---|
Histone Deacetylase Inhibitor SAHA Is a Promising Treatment of Cushing Disease.
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Adrenocorticotropic Hormone; Animals; Apoptosis; Blotting | 2017 |
Epigenetic silencing of CHD5, a novel tumor-suppressor gene, occurs in early colorectal cancer stages.
Topics: Adenoma; Azacitidine; Black or African American; Cell Line, Tumor; Cell Movement; Cell Proliferation | 2014 |
Suberoylanilide hydroxamic acid (SAHA) induces growth arrest and apoptosis in pituitary adenoma cells.
Topics: Adenoma; Animals; Antineoplastic Agents; Apoptosis; Caspases; Cell Cycle; Cell Proliferation; Dose-R | 2009 |
Epigenetic repression of DNA mismatch repair by inflammation and hypoxia in inflammatory bowel disease-associated colorectal cancer.
Topics: Adaptor Proteins, Signal Transducing; Adenoma; Adenosine Triphosphatases; Animals; Cell Hypoxia; Col | 2009 |